1 - 9 out of 9Page size: 10
  1. 2021

  2. Postoperative Complications and Long-Term Quality of Life After Multimodality Treatment for Esophageal Cancer: An Analysis of the Prospective Observational Cohort Study of Esophageal-Gastric Cancer Patients (POCOP)

    Jezerskyte, E., van Berge Henegouwen, M. I., van Laarhoven, H. W. M., van Kleef, J. J., Eshuis, W. J., Heisterkamp, J., Hartgrink, H. H., Rosman, C., van Hillegersberg, R., Hulshof, M. C. C. M., on behalf of the Dutch UpperGI Cancer Group, Sprangers, M. A. G. & Gisbertz, S. S., Nov 2021, In: Annals of surgical oncology. 28, 12, p. 7259-7276 18 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  3. Prognostic value of patient-reported quality of life for survival in oesophagogastric cancer: analysis from the population-based POCOP study

    On behalf of the Dutch Upper GI Cancer Group (DUCG), van Kleef, J. J., Dijksterhuis, W. P. M., van den Boorn, H. G., Prins, M., Verhoeven, R. H. A., Gisbertz, S. S., Slingerland, M., Mohammad, N. H., Creemers, G. J., Neelis, K. J., Heisterkamp, J., Rosman, C., Ruurda, J. P., Kouwenhoven, E. A., van de Poll-Franse, L. V., van Oijen, M. G. H., Sprangers, M. A. G. & van Laarhoven, H. W. M., Nov 2021, In: Gastric cancer. 24, 6, p. 1203-1212 10 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  4. Cachexia and dietetic interventions in patients with esophagogastric cancer: A Multicenter Cohort Study

    Dijksterhuis, W. P. M., Latenstein, A. E. J., van Kleef, J. J., Verhoeven, R. H. A., de Vries, J. H. M., Slingerland, M., Steenhagen, E., Heisterkamp, J., Timmermans, L. M., de van der Schueren, M. A. E., van Oijen, M. G. H., Beijer, S. & van Laarhoven, H. W. M., 2 Feb 2021, In: Journal of the National Comprehensive Cancer Network. 19, 2, p. 144-152 9 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  5. 2020

  6. Communicating treatment risks and benefits to cancer patients: a systematic review of communication methods

    van de Water, L. F., van Kleef, J. J., Dijksterhuis, W. P. M., Henselmans, I., van den Boorn, H. G., Vaarzon Morel, N. M., Schut, K. F., Daams, J. G., Smets, E. M. A. & van Laarhoven, H. W. M., 1 Jul 2020, In: Quality of life research. 29, 7, p. 1747-1766 20 p.

    Research output: Contribution to journal › Review article › Academic › peer-review

  7. External validation of the dutch SOURCE survival prediction model in belgian metastatic oesophageal and gastric cancer patients

    van Kleef, J. J., van den Boorn, H. G., Verhoeven, R. H. A., Vanschoenbeek, K., Abu-Hanna, A., Zwinderman, A. H., Sprangers, M. A. G., van Oijen, M. G. H., Schutter, H. D. & van Laarhoven, H. W. M., Apr 2020, In: Cancers. 12, 4, 834.

    Research output: Contribution to journal › Article › Academic › peer-review

  8. Quality of Life During Palliative Systemic Therapy for Esophagogastric Cancer: Systematic Review and Meta-Analysis: systematic review and meta-analysis

    van Kleef, J. J., ter Veer, E., van den Boorn, H. C. G., Schokker, S., Ngai, L. L., Prins, M. J., Mohammad, N. H., van de Poll-Franse, L. V., Zwinderman, A. H., van Oijen, M. G. H., Sprangers, M. A. G. & van Laarhoven, H. W. M., 1 Jan 2020, In: Journal of the National Cancer Institute. 112, 1, p. 12-29 18 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  9. 2019

  10. SOURCE: A Registry-Based Prediction Model for Overall Survival in Patients with Metastatic Oesophageal or Gastric Cancer

    van den Boorn, H. G., Abu-Hanna, A., Ter Veer, E., van Kleef, J. J., Lordick, F., Stahl, M., Ajani, J. A., Guimbaud, R., Park, S. H., Dutton, S. J., Bang, Y-J., Boku, N., Mohammad, N. H., Sprangers, M. A. G., Verhoeven, R. H. A., Zwinderman, A. H., van Oijen, M. G. H. & van Laarhoven, H. W. M., 5 Feb 2019, In: Cancers. 11, 2, p. E187 18 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  11. Phase I Dose escalation study with expansion cohort of the addition of nab-paclitaxel to capecitabine and oxaliplatin (CapOx) as first-line treatment of metastatic esophagogastric adenocarcinoma (ACTION study)

    Schokker, S., van der Woude, S. O., van Kleef, J. J., van Zoen, D. J., van Oijen, M. G. H., Mearadji, B., Beenen, L. F. M., Stroes, C. I., Waasdorp, C., Jibodh, R. A., Creemers, A., Meijer, S. L., Hooijer, G. K. J., Punt, C. J. A., Bijlsma, M. F. & van Laarhoven, H. W. M., 2019, In: Cancers. 11, 6, 827.

    Research output: Contribution to journal › Article › Academic › peer-review

  12. 2018

  13. Prospective observational cohort study of oesophagogastric cancer patients (POCOP): A Dutch nationwide cohort

    van Kleef, J. J., van de Poll-Franse, L. V., Verhoeven, R. H., Slingerland, M., Ruurda, J. P., Heisterkamp, J., Rosman, C., de Groot, J. W. B., Kouwenhoven, E. A., van Dijk, M. A., de Graaf, E., van Voorthuizen, T., Daams, F., Lagarde, S., Nieuwenhuijzen, G. A. P., Vincent, J., van Berge Henegouwen, M., van Oijen, M. G. H., Sprangers, M. A. G. & van Laarhoven, H. W. M., 2018, In: Annals of oncology. 29, p. viii234

    Research output: Contribution to journal › Article › Academic › peer-review

ID: 113216